Legal Opinion

In re Cerevel Therapeutics Holdings, Inc. Securities Litigation

District Court, D. Delaware

Decided June 15, 2026No. 1:25-cv-00417Unknown

1Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE IN RE CEREVEL THERAPEUTICS Civil Action No. 25-417-GBW HOLDINGS, INC. SECURITIES LITIGATION, MEMORANDUM ORDER Pending before the Court are three motions seeking certification of an interlocutory appeal or, in the alternate, reargument or reconsideration of the Court’s March 30, 2026 Opinion (D.I. 106) filed by Defendants Pfizer Inc. (“Pfizer”) (D.I. 115), Ron Renaud (“Renaud”) (D.I. 121) and Bain Capital Investors, LLC (“Bain”) (D.I. 122) (collectively, “Defendants” and “Defendants’ Motions”), which have been fully briefed (D.I.…

2Cases cited10 opinions

  1. Reuben J. Katz, on Behalf of Himself and All Others Similarly Situated v. Carte Blanche CorporationCourt of Appeals for the Third Circuit · 1974
  2. Institutional Investors Group v. Avaya, Inc.Court of Appeals for the Third Circuit · 2009
  3. In re Facebook, Inc., IPO Securities & Derivative LitigationDistrict Court, S.D. New York · 2014
  4. Stephanie Higgins v. Bayada Home Health Care IncCourt of Appeals for the Third Circuit · 2023
  5. Schering Corp. v. Amgen, Inc.District Court, D. Delaware · 1998

5 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API